| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $320.5M | -0.7% | +5.7% |
| Cost of Revenue | $199.2M | -2.6% | +4.2% |
| Gross Profit | $121.3M | +2.6% | +8.2% |
| R&D Expense | $14.1M | +3.6% | +12.0% |
| SG&A Expense | $78.8M | +6.5% | +11.5% |
| Operating Income | $27.2M | -11.9% | -3.8% |
| Pre-tax Income | $29.1M | -9.6% | -2.7% |
| Income Tax | $6.2M | -22.6% | -18.5% |
| Net Income | $20.9M | -6.3% | +3.3% |
| EPS (Basic) | $0.84 | -5.6% | +3.7% |
| EPS (Diluted) | $0.84 | -5.6% | +5.0% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $210.2M | +11.0% | +47.9% |
| Accounts Receivable | $42.7M | +0.4% | -5.3% |
| Current Assets | $572.8M | +4.0% | +23.9% |
| Total Assets | $678.3M | +3.6% | +17.8% |
| Current Liabilities | $308.4M | +1.0% | +10.9% |
| Total Liabilities | $310.1M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $28.2M | +377.9% | — |
| Capital Expenditures | $12.0M | +105.6% | — |
| Investing Cash Flow | -$21.4M | -133.0% | — |
| Financing Cash Flow | -$17.9M | -95.0% | — |
| Free Cash Flow | $16.2M | +201.6% | — |
| +10.5% |
| Stockholders' Equity | $339.7M | +5.9% | +25.1% |